Evidence map›Paper›PMID 34362671›Full record

ArticleCytokine & growth factor reviews2021

ORF8a as a viroporin in SARS-CoV-2 infection?

Milad Zandi

Open access · greenAbstract readComparative StudyLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cytokine & growth factor reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV.The European respiratory journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Milad ZandiDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Miladzandi416@gmail.com.
Iran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansOpen Reading FramesReproducibility of ResultsSARS-CoV-2Severe acute respiratory syndrome-related coronavirusViral Matrix ProteinsViral ProteinsViroporin ProteinsORF8 protein, SARS-CoV-2sars7a protein, SARS virusViral Matrix ProteinsViral ProteinsViroporin Proteins

Identifiers

PMID34362671
PMCPMC8327632
OpenAlexW3191991732

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.